Petřík Miloš Ph.D.

Petřík Miloš Ph.D.'s picture
Academic Title: PharmDr.
Phone: +420 585632125, +420 585632126
Curriculum Vitae: download
LinkedIn

Researcher experienced in the field of Nuclear Medicine with the main research interest in the preclinical development of radiolabelled agents for molecular imaging. He is a holder of European specialisation certificate in radiopharmacy; National coordinator of Imaging and Tracing platform for European Translational Medicine Infrastructure (EATRIS); actively participated in several national and international research projects. Published >30 scientific papers, >90 abstracts, >500 SCI citations, H-index 12.

Publication list: http://publicationslist.org/milospetrik

Orcid: https://orcid.org/0000-0003-1334-5916


Publications (Impact Factor Journals):

  • [18]
    PETŘÍK, M., E. UMLAUFOVÁ, V. RACLAVSKÝ, A. PALYZOVA, V. HAVLICEK, H. HAAS, Z. NOVÝ, D. DOLEŽAL, M. HAJDÚCH a C. DECRISTOFORO. Imaging of Pseudomonas aeruginosa infection with Ga-68 labelled pyoverdine for positron emission tomography. Scientific Reports. 2018, 8(1), 15698. ISSN 2045-2322 . IF: 4.122. PMID: 30356077
  • [17]
    SKRIBA, A., T. PLUHACEK, A. PALYZOVA, Z. NOVÝ, K. LEMR, M. HAJDÚCH, M. PETŘÍK a V. HAVLICEK. Early and Non-invasive Diagnosis of Aspergillosis Revealed by Infection Kinetics Monitored in a Rat Model. Frontiers in Microbiology. 2018, 9, 2356. ISSN 1664-302X. IF: 5.511. PMID: 30349512
  • [16]
    SUMMER, D., S. MAYR, M. PETŘÍK, C. RANGGER, K. SCHOELER, B. MATUSZCZAK a C. DECRISTOFORO. jeste nema IF_dostane Pristi rok_Pretargeted Imaging with Gallium-68-Improving the Binding Capability by Increasing the Number of Tetrazine Motifs. Pharmaceuticals (Basel, Switzerland). 2018, 11(4), pii: E102. ISSN 1424-8247. IF: x. PMID: 30314332
  • [15]
    LUPTAKOVA, D., T. PLUHACEK, M. PETŘÍK, J. NOVAK, A. PALYZOVA, L. SOKOLOVA, A. SKRIBA, B. SEDIVA, K. LEMR a V. HAVLICEK. Non-invasive and invasive diagnoses of aspergillosis in a rat model by mass spectrometry. Scientific Reports. 2017, 7(1), 16523. ISSN 2045-2322. IF: 4.529. PMID: 29184111
  • [14]
    VRABLIKOVA, A., L. CZERNEKOVA, R. CAHLIKOVA, Z. NOVÝ, M. PETŘÍK, S. IMRAN, Z. NOVÁK, M. KŘUPKA, V. CEROVSKY, J. TURANEK a M. RAŠKA. Lasioglossins LLIII affects the morphogenesis of Candida albicans and reduces the duration of experimental vaginal candidiasis in mice. Microbiology and Immunology. 2017, 61(11), 474-481. ISSN 0385-5600. IF: 1.706. PMID: 28892177
  • [13]
    SUMMER, D., L. GROSSRUBATSCHER, M. PETŘÍK, T. MICHALČÍKOVÁ, Z. NOVÝ, C. RANGGER, M. KLINGER, E. VON GUGGENBERG, R. HAUBNER, P. KAEOPOOKUM, H. HAAS a C. DECRISTOFORO. Developing targeted hybrid imaging probes by chelator scaffolding. Bioconjugate Chemistry. 2017, 28(6), 1722-1733. ISSN 1043-1802. IF: 4.500. PMID: 28462989
  • [12]
    PLUHACEK, T., M. PETŘÍK, D. LUPTAKOVA, O. BENADA, A. PALYZOVA, K. LEMR a V. HAVLÍČEK. Aspergillus infection monitored by multimodal imaging in a rat model. Proteomics. 2016, 16(11-12), 1785-1792. ISSN 1615-9853 . IF: 4.041. PMID: 27060291
  • [11]
    ZHAI, C., G. FRANSSEN, M. PETŘÍK, P. LAVERMAN, D. SUMMER, C. RANGGER, R. HAUBNER, H. HAAS a C. DECRISTOFORO. Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [68Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors. Molecular Imaging and Biology. 2016, 18(5), 758-67. ISSN 1536-1632. IF: 3.466. PMID: 26905697
  • [10]
    PFISTER, J., D. SUMMER, C. RANGGER, M. PETŘÍK, E. VON GUGGENBERG, P. MINAZZI, G. GIOVENZANA, L. ALOJ a C. DECRISTOFORO. Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue. European Journal of Nuclear Medicine and Molecular Imaging Research. 2015, 5(74), 1-11. ISSN 2191-219X. IF: 1.761. PMID: 26669693
  • [9]
    PETŘÍK, M., C. ZHAI, Z. NOVÝ, L. URBANEK, H. HAAS a C. DECRISTOFORO. In vitro and in vivo comparison of selected Ga-68 and Zr-89 labelled siderophores. Molecular Imaging and Biology. 2015, 18(3), 344-52. ISSN 1860-2002. IF: 2.569. PMID: 26424719
  • [8]
    ZHAI, C., D. SUMMER, C. RANGGER, G. FRANSSEN, P. LAVERMAN, H. HAAS, M. PETŘÍK, R. HAUBNER a C. DECRISTOFORO. Novel Bifunctional Cyclic Chelator for (89)Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates. Molecular Pharmaceutics. 2015, 12(6), 2142-2150. ISSN 1543-8384. IF: 4.342. PMID: 25941834
  • [7]
    HAAS, H., M. PETŘÍK a C. DECRISTOFORO. An iron-mimicking Trojan horse entering fungi - has the time come for molecular imaging of fungal infections?. PLOS Pathogens. 2015, 11(1), 1-7. ISSN 1553-7366. IF: 7.003. PMID: 25634225
  • [6]
    PETŘÍK, M., A. VLČKOVÁ, Z. NOVÝ, L. URBANEK, H. HAAS a C. DECRISTOFORO. Selected 68Ga-siderophores versus 68Ga-colloid and 68Ga-citrate: biodistribution and small animal imaging in mice. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2015, 159(1), 60-66. ISSN 1213-8118. IF: 0.924. PMID: 25363728
  • [5]
    MATTOVA, J., P. POUCKOVA, J. KUCKA, M. SKODOVA, M. VETRIK, P. STEPANEK, P. URBANEK, M. PETŘÍK, Z. NOVÝ a M. HRUBY. Chelating polymeric beads as potential therapeutics for Wilson's disease. European Journal of Pharmaceutical Sciences. 2014, 62(-), 1-7. ISSN 0928-0987. IF: 3.350. PMID: 24815561
  • [4]
    PETŘÍK, M., H. HAAS, P. LAVERMAN, M. SCHRETTL, G. FRANSSEN, M. BLATZER a C. DECRISTOFORO. 68Ga-Triacetylfusarinine C and 68Ga-Ferrioxamine E for Aspergillus Infection Imaging: Uptake Specificity in Various Microorganisms. Molecular Imaging and Biology. 2014, 16(1), 102-108. ISSN 1536-1632. IF: 2.774. PMID: 23102540
  • [3]
    KNETSCH, P.A., M. PETŘÍK, C. RANGGER, G. SEIDEL, H.J. PIETZSCH, I. VIRGOLINI, C. DECRISTOFORO a R. HAUBNER. [(68)Ga]NS(3)-RGD and [(68)Ga] Oxo-DO3A-RGD for imaging α(v)β(3) integrin expression: synthesis, evaluation, and comparison. Nuclear Medicine and Biology. 2013, 40(1), 65-72. ISSN 0969-8051. IF: 2.408. PMID: 23102540
  • [2]
    PETŘÍK, M., A. SCHUESSELE, S. PERKHOFER, C. LASS-FLÖRL, D. BECKER a C. DECRISTOFORO. Microbial challenge tests on nonradioactive TiO2-based 68Ge/68Ga generator columns. Nuclear Medicine Communications. 2012, 33(8), 819-823. ISSN 0143-3636. IF: 1.379. PMID: 22546876
  • [1]
    PETŘÍK, M., G. FRANSSEN, H. HAAS, P. LAVERMAN, C. HÖRTNAGL, M. SCHRETTL, A. HELBOK, C. LASS-FLÖRL a C. DECRISTOFORO. Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging. European Journal of Nuclear Medicine and Molecular Imaging. 2012, 39(7), 1175-1183. ISSN 1619-7070. IF: 5.114. PMID: 22526953

Publications (Other Reviewed Journals):

  • [1]
    PETŘÍK, M., C. ZHAI, H. HAAS a C. DECRISTOFORO. Siderophores for molecular imaging applications. Clinical and Translational Imaging. 2016, 5(1), 15-27. ISSN 2281-5872 . PMID: 28 138 436

Patents, Utility models & other IP's :

[1] NANOPARTICLES BASED ON HYDROXYAPATITE AND HYDROPHILIC POLYMER FOR THE USE IN BIOLOGY AND MEDICINE, PUV 2018-35276

Utility Patent: CZ 32279; Granted: 6. 11. 2018; Ownership: Institute of Macromolecular Chemistry, Czech Academy of Sciences, Palacky University, Olomouc; Inventors: Hrubý Martin, Petřík Miloš, Lobaz Volodymyr, Nový Zbyněk

​Status: Available 



Master students mentor:

[3] Libuše Pechová, Preclinical evaluation of 68Ga-siderophores for Candida albicans detection,
status: Ongoing, from: 2018
[2] Romana Christová, Radiolabelled siderophore derivatives for detection of cancer and infection,
status: Graduated, from: 2017 to 2018
[1] Eva Umlaufová, Preclinical evaluation of 68Ga-pyoverdines for Pseudomonas imaging,
status: Graduated, from: 2016 to 2018


Bachelor students mentor:

[6] Aneta Puskásová, In vitro and in vivo evaluation of radiolabelled ornibactin ,
status: Ongoing, from: 2018
[5] Michaela Kučerková, Study of pharmacokinetics selected radiopharmaceuticals in animal models using imaging methods,
status: Graduated, from: 2013 to 2014
[4] Eva Umlaufová, 68Ga-siderophores of Pseudomonas species,
status: Graduated, from: 2015 to 2016
[3] Tereza Michalčíková, Labelled peptides for multimodal in vivo imaging of cancer,
status: Graduated, from: 2016 to 2017
[2] Jana Štěpánková, Preclinical development of 68Ga labelled peptides for glioblastoma imaging,
status: Graduated, from: 2014 to 2015
[1] Adéla Vlčková, Studium farmakokinetiky 68Ga značených sideroforů v laboratorních zvířatech,
status: Graduated, from: 2013 to 2014